Oruka Therapeutics Inc. Common Stock vs Sotera Health Company Common Stock — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while Sotera Health Company Common Stock trades at $17.68 (market cap $5.20B). The key difference: Oruka Therapeutics Inc. Common Stock and Sotera Health Company Common Stock are close in size by market cap, and Sotera Health Company Common Stock is trading nearer its 52-week high, Oruka Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Sotera Health Company Common Stock for 0 Days on average.
| ORKA | SHC | |
|---|---|---|
Market Cap | $5.18B | $5.20B |
Volume | 490,798 | 1,647,777 |
Sector | Health | Health |
52-Week High | $113.08 | $19.57 |
52-Week Low | $26.19 | $13.13 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.31B | $7.11B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →Sotera Health Company is a US provider of sterilization and lab testing services for the healthcare industry, operating through its Sterigenics, Nordion, and Nelson Labs businesses.
Read more on SHC →